Mitochondrial peptides, CNS modulators, and NAD+ precursors for buyers chasing sustained daytime energy without stimulant crashes. COA-verified vendors only.
Direct NAD+ delivery — bypasses NMN conversion. 99.6% purity, lab-tested per batch. View product →
by Aeon Labs · ★ 4.9 (1,047 reviews)A 16-amino-acid peptide encoded in mitochondrial DNA that improves insulin sensitivity, glucose utilization, and exercise capacity in published animal models. Often the #1 sustained-energy peptide for buyers with metabolic plateau or mid-afternoon crashes.
Direct nicotinamide adenine dinucleotide — the central electron-transport cofactor. Subcutaneous protocol delivers more bioavailable NAD+ than oral NMN. Cross-shops heavily with anti-aging buyers since NAD+ levels decline ~50% by middle age.
Russian-developed heptapeptide derived from ACTH(4-10). Increases BDNF and modulates dopaminergic and serotonergic systems. Most useful for buyers whose "low energy" is actually cognitive fatigue rather than mitochondrial deficit.
Higher-concentration MOTS-c vial for users running an established protocol — fewer reconstitutions, lower cost per mg. Stack partner with NAD+ for buyers chasing maximum mitochondrial throughput.
Multi-dose NAD+ vial for long-protocol users — typically a 10-week loading phase followed by maintenance. Reconstitution recommended with bacteriostatic water at 100 mg/mL for ease of dosing. Frequently paired with MOTS-c.
Energy is the second-most-searched category on Peptide.best, but it's also the most poorly diagnosed. "I'm tired" can mean mitochondrial dysfunction, low NAD+, poor sleep architecture (a sleep problem disguised as energy), low thyroid, low testosterone, or cognitive overload. The three peptides in this category target three different mechanisms — picking the right one is the most important decision a buyer can make.
MOTS-c is one of the rare peptides encoded directly in mitochondrial DNA (rather than nuclear DNA). It improves insulin sensitivity, increases glucose utilization in muscle tissue, and improves exercise capacity in rodent studies. The lived experience that buyers report most often: stable energy curves, less post-meal slump, better second-half-of-workout performance. Typical protocol is 5–10 mg twice weekly via subcutaneous injection.
Nicotinamide adenine dinucleotide is the central electron carrier of the cell — every ATP molecule produced via oxidative phosphorylation requires NAD+ as a cofactor. Tissue NAD+ concentrations decline roughly 50% between ages 20 and 60, which is why NAD+ sits in both the energy and anti-aging categories. Subcutaneous NAD+ bypasses the gut-absorption problem that plagues oral NMN and NR precursors, delivering substantially higher tissue levels.
Semax is the odd peptide out here — it doesn't work on mitochondria, it works on the brain. Derived from the ACTH fragment, it increases BDNF and modulates dopaminergic tone. The effect is closer to a clean, sustained nootropic boost than to a stimulant. Most useful for knowledge workers whose "energy crash" is really attentional fatigue. The nasal spray format makes it appealing for needle-averse buyers.
MOTS-c is well-tolerated in studied dose ranges; rare reports of injection-site reactions. NAD+ injection commonly causes a flushing or pressure sensation if injected too fast — go slow, especially during the loading phase. Semax has the lightest side-effect profile (mild nasal irritation in some users). None of these are FDA-approved for energy or anti-fatigue indications. Always consult a licensed healthcare provider, particularly if you take stimulants, MAO inhibitors, or have cardiovascular conditions.
| If your issue is... | Start with | Why |
|---|---|---|
| Mitochondrial / metabolic fatigue | MOTS-c | Direct mitochondrial-DNA-encoded peptide |
| Age-related cellular fatigue | NAD+ | Replaces declining cofactor |
| Cognitive / mental fatigue | Semax | BDNF and dopaminergic modulation |
| Broad "feel younger" goal | MOTS-c + NAD+ stack | Mitochondrial + cofactor coverage |
| Need fast onset, no needles | Semax nasal | Crosses BBB within minutes |
Want the full deep-dive? Read our complete guide to peptides for energy with dosing schedules, citations, and stacking protocols.
For raw tissue-level NAD+, yes — subcutaneous NAD+ achieves substantially higher serum and tissue concentrations than oral NMN or NR, which lose significant signal to gut metabolism. The trade-off is the needle. Many buyers run an injection loading phase followed by oral maintenance.
Yes — this is one of the most common energy stacks on Peptide.best. The mechanisms are complementary (MOTS-c improves mitochondrial efficiency while NAD+ replenishes the cofactor that mitochondria need). Dose them on different days or at different times to make side-effect attribution easier.
Less than coffee. Most users dose Semax in the morning and early afternoon and report no sleep disruption. If you're sensitive to stimulants, start with a single-dose morning protocol and avoid evening administration.
Semax effects are felt within 15–30 minutes of administration. MOTS-c and NAD+ are slower — most users report perceptible energy stability after 7–14 days of consistent dosing. Track with subjective energy scoring and HRV via Oura or WHOOP.